Log in

Relevant bibliographies by topics / Human primary liver cancer / Books

Books on the topic 'Human primary liver cancer'

To see the other types of publications on this topic, follow the link: Human primary liver cancer.

Author: Grafiati

Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Human primary liver cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Reau, Nancy, and Fred Poordad, eds. Primary Liver Cancer. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-863-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gu, Jianren. Primary Liver Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28702-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Chao-yu, Tʼang, Wu Meng-chʼao, and Hsia Sui-sheng, eds. Primary liver cancer. Beijing: China Academic Publishers, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Tobe, Takayoshi, Haruo Kameda, Masahiko Okudaira, Masao Ohto, Yasuo Endo, Michio Mito, Eizo Okamoto, Kyuichi Tanikawa, and Masamichi Kojiro, eds. Primary Liver Cancer in Japan. Tokyo: Springer Japan, 1992. http://dx.doi.org/10.1007/978-4-431-68177-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Takayoshi, Tobe, ed. Primary liver cancer in Japan. Tokyo: Springer-Verlag, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Williams, Roger, and Simon D. Taylor-Robinson, eds. Clinical Dilemmas in Primary Liver Cancer. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781119962205.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

K, Hussain Hero, and Francis Isaac R, eds. Primary carcinomas of the liver. Cambridge: Cambridge University Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Reau, Nancy, and Fred Poordad. Primary liver cancer: Surveillance, diagnosis, and treatment. New York: Humana Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

1933-, Herfarth Christian, Schlag P. 1948-, and Hohenberger P. 1953-, eds. Therapeutic strategies in primary and metastatic liver cancer. Berlin: Springer-Verlag, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Felix, Lee, ed. Liver cancer: New research. New York: Nova Science Publishers, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Herfarth, Christian, Peter Schlag, and Peter Hohenberger, eds. Therapeutic Strategies in Primary and Metastatic Liver Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-82635-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Cady, Blake. Management options in primary and secondary liver cancer. Philadelphia: W.B. Saunders, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Masters, J. R. W., ed. Human Cancer in Primary Culture, A Handbook. Dordrecht: Springer Netherlands, 1991. http://dx.doi.org/10.1007/978-94-011-3304-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

W, Masters John R., ed. Human cancer in primary culture: A handbook. Dordrecht: Kluwer Academic Publishers, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

1925-, Blumberg Baruch S., ed. Hepatitis B and the prevention of primary cancer of the liver: Selected publications of Baruch S. Blumberg. Singapore: World Scientific, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

service), SpringerLink (Online, ed. Multiple Primary Malignancies. Milano: Springer Milan, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

1931-, Chambers P. L., Henschler Dietrich, and Oesch Franz 1938-, eds. Mouse liver tumors: Relevance to human cancer risk : Symposium of the European Society of Toxicology, held in Rome, February 2-5, 1986. Berlin: Springer-Verlag, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Clinical Dilemmas In Primary Liver Cancer. Wiley-Blackwell, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

undifferentiated, Roger Williams, and Simon D. Taylor-Robinson. Clinical Dilemmas in Primary Liver Cancer. Wiley & Sons, Incorporated, John, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

undifferentiated, Roger Williams, and Simon D. Taylor-Robinson. Clinical Dilemmas in Primary Liver Cancer. Wiley & Sons, Incorporated, John, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

undifferentiated, Roger Williams, and Simon D. Taylor-Robinson. Clinical Dilemmas in Primary Liver Cancer. Wiley & Sons, Incorporated, John, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

22

Bamia, Christina, Sherri Stuver, and Lorelei Mucci. Cancer of the Liver and Biliary Tract. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0012.

Full text

Abstract:

Primary liver cancer is one of the most commonly occurring cancers globally, and is the second most common cause of cancer death worldwide. There are two major histologic forms of primary liver cancer: hepatocellular carcinoma (HCC) and cholangiocarcinoma. It is a rapidly and almost uniformly fatal disease, yet there is already sufficient knowledge about its major risk factors, many of which are modifiable, to make primary prevention effective. Primary liver cancer is one of the first common human cancer that was found to have an infectious etiology, with hepatitis B virus (HBV) and hepatitis C virus (HCV) for HCC, and parasitic liver flukes for cholangiocarcinoma. Obesity is emerging as an important risk factor, particularly in Western countries, where primary liver cancer rates appear to be increasing over time. A number of additional risk factors and potential preventive factors are considered in this chapter.

APA, Harvard, Vancouver, ISO, and other styles

23

Gapstur, Susan M., and Philip John Brooks. Alcohol and Cancer Risk. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0012.

Full text

Abstract:

In 2010, alcoholic beverage consumption caused an estimated 3.3 million deaths worldwide, and contributed to injuries, violence, liver cirrhosis, social disruption and at least seven different types of cancer. The International Agency for Research on Cancer (IARC) classifies exposure to both ethanol in alcoholic beverages and acetaldehyde, the primary metabolite of ethanol, as carcinogenic to humans (Group 1) based on “sufficient” evidence that alcoholic beverage consumption is causally related to cancers of the oral cavity, pharynx, larynx, esophagus, liver, colorectum and female breast. The biologic mechanisms by which alcohol and its primary metabolite acetaldehyde affect cancer risk appear to vary across anatomic sites. Broadly, these mechanisms involve DNA and protein damage from acetaldehyde and oxidative stress, nutritional malabsorption and metabolic effects, and for breast cancer, increased estrogen levels. The World Health Organization has increased global surveillance of alcohol consumption and encourages national efforts to apply evidence-based policies to reduce consumption.

APA, Harvard, Vancouver, ISO, and other styles

24

Tobe, Takayoshi. Primary Liver Cancer in Japan. Springer, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

25

Tobe, Takayoshi, Haruo Kameda, Masahiko Okudaira, Masao Ohto, and Yasuo Endo. Primary Liver Cancer in Japan. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

26

Gu, Jianren. Primary Liver Cancer: Challenges and Perspectives. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

27

Gu, Jianren. Primary Liver Cancer: Challenges and Perspectives. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

28

undifferentiated, Roger Williams, and Simon D. Taylor-Robinson. Clinical Dilemmas in Primary Liver Cancer. Wiley & Sons, Limited, John, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

Gu, Jianren. Primary Liver Cancer: Challenges and Perspectives. Springer London, Limited, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

Reau, Nancy, and Fred Poordad. Primary Liver Cancer: Surveillance, Diagnosis and Treatment. Humana Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

Reau, Nancy, and Fred Poordad. Primary Liver Cancer: Surveillance, Diagnosis and Treatment. Humana Press, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

32

Primary liver cancer: Etiological and progression factors. Boca Raton: CRC Press, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

33

A case of primary cancer of the liver. [S.l: s.n., 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Keshav, Satish, and Palak Trivedi. Liver cancer. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0218.

Full text

Abstract:

Primary hepatocellular carcinoma (HCC) arises from hepatocytes and is one of the commonest solid-organ malignancies in the world, particularly in the Far East and in sub-Saharan Africa. Cholangiocarcinoma arises from the biliary epithelium. The incidence is rising in the West, and primary sclerosing cholangitis (PSC) is an important risk factor (15% lifetime risk). Other forms of liver cancer include metastatic cancer, which is much more common in the West than any primary liver cancer, accounting for 90% of liver cancers and for which common primary sites are the colon, the stomach, the breasts, and the lungs; hepatoblastoma, which is an uncommon malignancy in children, originating from immature liver cell precursors; haemangiosarcomas, which are also rare, are malignant tumours arising from the blood vessels in the liver and can be very rapidly growing; and gall bladder cancer, arising from the gall bladder epithelium. Gallstones and PSC are risk factors for gall bladder cancer; in particular, PSC confers a risk >160 times that of the control population. This chapter primarily focuses on HCC.

APA, Harvard, Vancouver, ISO, and other styles

35

Herfarth, Ch. Therapeutic Strategies in Primary and Metastatic Liver Cancer. Springer-Verlag, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

36

Therapeutic Strategies in Primary and Metastatic Liver Cancer. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Herfarth, Christian, Peter Hohenberger, and Peter Schlag. Therapeutic Strategies in Primary and Metastatic Liver Cancer. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Thomas London, W., Jessica L. Petrick, and Katherine A. McGlynn. Liver Cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0033.

Full text

Abstract:

Primary liver cancer is the sixth most frequently occurring cancer in the world and the second most common in terms of cancer deaths. The global burden of liver cancer is borne principally by countries in East Asia and Africa, where 80% of liver cancer arises. Incidence rates of liver cancer, however, have begun to decline in Asia, while rates are increasing in low-rate areas such as Europe and North America. The dominant histology of liver cancer in almost all countries is hepatocellular carcinoma (HCC). The major risk factors for HCC—chronic infection with either hepatitis B virus (HBV) or hepatitis C virus (HCV), aflatoxin B1 (AFB1) contamination of foodstuffs, excessive alcohol consumption, and diabetes/obesity/fatty liver disease—all result in chronic inflammation in the liver. HBV infection is preventable by immunization, and HCV infection is largely preventable by public health measures and now is curable with new antiviral therapies.

APA, Harvard, Vancouver, ISO, and other styles

39

Cardona, Kenneth, and Shishir K. Maithel. Primary and Metastatic Liver Tumors: Treatment Strategy and Evolving Therapies. Springer, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

40

Cardona, Kenneth, and Shishir K. Maithel. Primary and Metastatic Liver Tumors: Treatment Strategy and Evolving Therapies. Springer, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

41

(Editor), Mark S. Talamonti, and Sam G. Pappas (Editor), eds. Liver-Directed Therapy for Primary and Metastatic Liver Tumors (Cancer Treatment and Research). Springer, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Pappas, Sam G., and Mark S. Talamonti. Liver-Directed Therapy for Primary and Metastatic Liver Tumors. Springer, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

Chen, Jiang, Jian Chen, Zhigang Ren, Xiaochen Wang, and Qiuran Xu, eds. The Role of Tumor Microenvironment in Primary Liver Cancer Therapeutic Resistance. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-882-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Blumberg, Baruch S. Hepatitis B and the Prevention of Primary Cancer of the Liver. WORLD SCIENTIFIC, 2000. http://dx.doi.org/10.1142/3550.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Masters, John. Human Cancer In Primary Culture, A Handbook. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Masters, John. Human Cancer in Primary Culture, a Handbook. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

Bulterys, Marc, Julia Brotherton, and Ding-Shinn Chen. Prevention of Infection-Related Cancers. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0066.

Full text

Abstract:

This chapter discusses primary prevention measures that disrupt transmission of oncogenic infections. It begins by discussing vaccination against hepatitis B virus (HBV) and human papillomavirus (HPV), two major causes of cancer for which safe and effective vaccines are currently available. It briefly discusses the importance of treatment and prophylaxis against human immunodeficiency virus type 1 (HIV-1), which potentiates the virulence of other viral infections as well as directly increasing the incidence of non-Hodgkin lymphoma. It does not discuss the treatment of HBV or hepatitis C virus (HCV) infection, since these are considered in Chapters 25 and 33. Also beyond the scope of this chapter are the randomized clinical trials currently underway to assess the efficacy and feasibility of eradication of Helicobacter pylori (Chapters 24, 31), vaccination against Epstein-Barr virus (EBV) (Chapters 24, 26, 39), or the prevention of schistosomiasis and liver flukes (Chapters 24, 33, and 52).

APA, Harvard, Vancouver, ISO, and other styles

48

Viruses and Liver Cancer (Perspectives in Medical Virology). Elsevier Science, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Chambers, Philip L., and D. Henschler. Mouse Liver Tumors: Relevance to Human Cancer Risk (Archives of Toxicology Supplement). Springer-Verlag, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Hayat, M. A. Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas : Molecular Genetics: Liver and Pancreatic Carcinomas V3. Elsevier Science & Technology Books, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!